DD106181A5 - - Google Patents
Info
- Publication number
- DD106181A5 DD106181A5 DD171185A DD17118573A DD106181A5 DD 106181 A5 DD106181 A5 DD 106181A5 DD 171185 A DD171185 A DD 171185A DD 17118573 A DD17118573 A DD 17118573A DD 106181 A5 DD106181 A5 DD 106181A5
- Authority
- DD
- German Democratic Republic
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US00258767A US3819620A (en) | 1972-06-01 | 1972-06-01 | 7-(d-alpha-amino-1,4-cyclohexadien-1-ylacet-amido)desacetoxycephalosporanic acid dihydrate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD106181A5 true DD106181A5 (de) | 1974-06-05 |
Family
ID=22982041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD171185A DD106181A5 (de) | 1972-06-01 | 1973-05-30 |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US3819620A (de) |
| JP (1) | JPS5544754B2 (de) |
| KR (1) | KR820001606B1 (de) |
| AR (1) | AR196669A1 (de) |
| AT (1) | AT322740B (de) |
| AU (1) | AU475833B2 (de) |
| BE (1) | BE800373A (de) |
| BR (1) | BR7303959D0 (de) |
| CA (1) | CA1004220A (de) |
| CH (1) | CH582185A5 (de) |
| CS (1) | CS178428B2 (de) |
| DD (1) | DD106181A5 (de) |
| DE (1) | DE2326880C2 (de) |
| EG (1) | EG11139A (de) |
| ES (1) | ES415420A1 (de) |
| FI (1) | FI57952C (de) |
| FR (1) | FR2186234B1 (de) |
| GB (1) | GB1426266A (de) |
| HU (1) | HU167052B (de) |
| IE (1) | IE38750B1 (de) |
| IL (1) | IL42243A (de) |
| IN (1) | IN138787B (de) |
| IT (1) | IT1068202B (de) |
| NL (1) | NL176267C (de) |
| NO (1) | NO144849C (de) |
| PL (1) | PL87262B1 (de) |
| RO (2) | RO63443A (de) |
| SE (1) | SE409714B (de) |
| SU (1) | SU465793A3 (de) |
| ZA (1) | ZA732889B (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5725557B2 (de) * | 1972-11-17 | 1982-05-29 | ||
| CH619233A5 (de) * | 1975-07-31 | 1980-09-15 | Ciba Geigy Ag | |
| US4054738A (en) * | 1975-12-22 | 1977-10-18 | Eli Lilly And Company | Sodium cefamandole crystalline forms |
| US4946838A (en) * | 1981-07-13 | 1990-08-07 | E. R. Squibb & Sons, Inc. | Crystalline anhydrous aztreonam |
| NZ220764A (en) * | 1986-07-02 | 1989-09-27 | Shionogi & Co | Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions |
| US4977257A (en) * | 1988-11-14 | 1990-12-11 | Eli Lilly And Company | DMF solvates of a β-lactam antibiotic |
| ES2023560A6 (es) * | 1989-07-10 | 1992-01-16 | Gema Sa | Procedimiento para la produccion de hidrato de cefradina y solvato de cefradina y dimetilformamida. |
| US5278157A (en) * | 1989-07-10 | 1994-01-11 | Gema, S.A. | Stable cephradine hydrate |
| IT1289955B1 (it) * | 1997-02-21 | 1998-10-19 | Solchem Italiana Spa | Acyclovir sale sodico biidrato e sua preparazione |
| CN1326860C (zh) * | 2002-08-06 | 2007-07-18 | 北京化工大学 | 头孢拉定晶体以及制备头孢拉定的方法 |
| WO2005003367A2 (en) * | 2003-07-03 | 2005-01-13 | Dsm Ip Assets B.V. | Process for the preparation of cephradine |
| CN104688713A (zh) * | 2015-03-20 | 2015-06-10 | 江苏亚邦强生药业有限公司 | 一种头孢拉定胶囊剂及其制备方法 |
| CN112206217A (zh) * | 2020-10-21 | 2021-01-12 | 迪沙药业集团有限公司 | 一种头孢拉定药物组合物及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3485819A (en) * | 1968-07-02 | 1969-12-23 | Squibb & Sons Inc | Alpha-amino-cyclohexadienylalkylene-penicillins and cephalosporins |
-
1972
- 1972-06-01 US US00258767A patent/US3819620A/en not_active Expired - Lifetime
-
1973
- 1973-04-27 ZA ZA732889A patent/ZA732889B/xx unknown
- 1973-04-27 CA CA169,770A patent/CA1004220A/en not_active Expired
- 1973-05-01 AU AU55074/73A patent/AU475833B2/en not_active Expired
- 1973-05-01 IE IE685/73A patent/IE38750B1/xx unknown
- 1973-05-04 GB GB2136873A patent/GB1426266A/en not_active Expired
- 1973-05-11 IL IL42243A patent/IL42243A/xx unknown
- 1973-05-15 AT AT425673A patent/AT322740B/de not_active IP Right Cessation
- 1973-05-16 CH CH698773A patent/CH582185A5/xx not_active IP Right Cessation
- 1973-05-18 FI FI1619/73A patent/FI57952C/fi active
- 1973-05-21 IN IN1185/CAL/73A patent/IN138787B/en unknown
- 1973-05-22 IT IT50132/73A patent/IT1068202B/it active
- 1973-05-24 JP JP5818273A patent/JPS5544754B2/ja not_active Expired
- 1973-05-25 NL NLAANVRAGE7307321,A patent/NL176267C/xx active Search and Examination
- 1973-05-25 KR KR7300849A patent/KR820001606B1/ko active
- 1973-05-25 DE DE2326880A patent/DE2326880C2/de not_active Expired
- 1973-05-28 PL PL1973162890A patent/PL87262B1/pl unknown
- 1973-05-29 BR BR3959/73A patent/BR7303959D0/pt unknown
- 1973-05-29 SU SU1926947A patent/SU465793A3/ru active
- 1973-05-29 CS CS3874A patent/CS178428B2/cs unknown
- 1973-05-29 AR AR248270A patent/AR196669A1/es active
- 1973-05-30 ES ES415420A patent/ES415420A1/es not_active Expired
- 1973-05-30 SE SE7307739A patent/SE409714B/xx unknown
- 1973-05-30 EG EG203/73A patent/EG11139A/xx active
- 1973-05-30 HU HUSU817A patent/HU167052B/hu unknown
- 1973-05-30 DD DD171185A patent/DD106181A5/xx unknown
- 1973-05-30 NO NO2277/73A patent/NO144849C/no unknown
- 1973-06-01 FR FR7320002A patent/FR2186234B1/fr not_active Expired
- 1973-06-01 RO RO7300075001A patent/RO63443A/ro unknown
- 1973-06-01 RO RO7385108A patent/RO68286A/ro unknown
- 1973-06-01 BE BE131807A patent/BE800373A/xx not_active IP Right Cessation